[company_age]5.0[/company_age][employees]2-10 employees[/employees][funding]Undisclosed[/funding][description]GyreOx is a drug discovery company that uses a unique macrocyclic platform to develop novel therapeutics. The company was founded in 2019 as a spinout from the University of Oxford and is headquartered at the Harwell Campus in Oxfordshire. GyreOx's platform technology is protected by four patent applications and allows for the rapid discovery of drug-like gyrocycles. The company's proprietary discovery platform is used to create unique and highly modified macrocyclic compounds called 'gyrocycles'. Gyrocycles combine the target-engagement power of biologics with the cell-entry ability of small molecules.[/description][ps]Drug discovery platform, gyrocycles[/ps]